ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy.
Zhai J, Chen H, Wong CC, Peng Y, Gou H, Zhang J, Pan Y, Chen D, Lin Y, Wang S, Kang W, To KF, Chen Z, Nie Y, He HH, Sung JJ, Yu J.
Zhai J, et al. Among authors: peng y.
Gastroenterology. 2023 Aug;165(2):445-462. doi: 10.1053/j.gastro.2023.04.032. Epub 2023 May 9.
Gastroenterology. 2023.
PMID: 37169182
Free article.